Cargando…
The role of IL-1B in breast cancer bone metastasis
Approximately 75% of patients with late-stage breast cancer will develop bone metastasis. This condition is currently considered incurable and patients’ life expectancy is limited to 2–3 years following diagnosis of bone involvement. Interleukin (IL)-1B is a pro-inflammatory cytokine whose expressio...
Autores principales: | Tulotta, Claudia, Ottewell, Penelope |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987176/ https://www.ncbi.nlm.nih.gov/pubmed/29760166 http://dx.doi.org/10.1530/ERC-17-0309 |
Ejemplares similares
-
Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis
por: Zhou, Jiabao, et al.
Publicado: (2022) -
IL-1 drives breast cancer growth and bone metastasis in vivo
por: Holen, Ingunn, et al.
Publicado: (2016) -
The role of osteoblasts in bone metastasis
por: Ottewell, Penelope D
Publicado: (2016) -
Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts
por: Lefley, Diane, et al.
Publicado: (2019) -
IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer
por: Tulotta, Claudia, et al.
Publicado: (2021)